Potent GHRH analog and the only peptide in this class FDA-approved for reducing visceral adiposity in patients with HIV-associated lipodystrophy. It promotes GH and IGF-1 release, leading to reduced abdominal fat and improved body composition, while preserving lean muscle mass. 

Stimulates GH secretion through pituitary GHRH receptors Increases IGF-1 levels to enhance lipolysis and tissue repair Reduces visceral fat while maintaining lean mass.